- Home
- CRBP vs SSBK Comparison
CRBP vs SSBK Comparison
Compare CRBP & SSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- SSBK
- Stock Information
- Founded
- CRBP 2009
- SSBK 2007
- Country
- CRBP United States
- SSBK United States
- Employees
- CRBP N/A
- SSBK N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- SSBK Commercial Banks
- Sector
- CRBP Health Care
- SSBK Finance
- Exchange
- CRBP Nasdaq
- SSBK Nasdaq
- Market Cap
- CRBP 227.3M
- SSBK 258.6M
- IPO Year
- CRBP N/A
- SSBK 2021
- Fundamental
- Price
- CRBP $16.73
- SSBK $36.83
- Analyst Decision
- CRBP Strong Buy
- SSBK Buy
- Analyst Count
- CRBP 7
- SSBK 1
- Target Price
- CRBP $65.86
- SSBK $36.00
- AVG Volume (30 Days)
- CRBP 346.4K
- SSBK 24.4K
- Earning Date
- CRBP 11-07-2024
- SSBK 10-21-2024
- Dividend Yield
- CRBP N/A
- SSBK 0.96%
- EPS Growth
- CRBP N/A
- SSBK N/A
- EPS
- CRBP N/A
- SSBK 3.52
- Revenue
- CRBP N/A
- SSBK $87,115,000.00
- Revenue This Year
- CRBP N/A
- SSBK N/A
- Revenue Next Year
- CRBP N/A
- SSBK $11.75
- P/E Ratio
- CRBP N/A
- SSBK $10.36
- Revenue Growth
- CRBP N/A
- SSBK 1.89
- 52 Week Low
- CRBP $4.00
- SSBK $22.13
- 52 Week High
- CRBP $61.90
- SSBK $37.86
- Technical
- Relative Strength Index (RSI)
- CRBP 37.25
- SSBK 65.67
- Support Level
- CRBP $15.65
- SSBK $35.21
- Resistance Level
- CRBP $17.18
- SSBK $36.94
- Average True Range (ATR)
- CRBP 1.26
- SSBK 1.35
- MACD
- CRBP 0.35
- SSBK 0.10
- Stochastic Oscillator
- CRBP 21.09
- SSBK 84.99
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About SSBK Southern States Bancshares Inc.
Southern States Bancshares Inc is a full-service community banking institution, that offers an array of deposit, loan, and other banking-related products and services to businesses and individuals in communities. It has three portfolio segments Real estate, Commercial and industrial, Consumer and other.